Sally Cluchey, MS
Senior Research Associate, Engelberg Center for Health Care Reform
Sally Cluchey is a senior research associate with the Engelberg Center for Health Care Reform at The Brookings Institution. There she manages a cooperative agreement with the Food and Drug Administration to convene discussions among multiple stakeholders and experts related to the development of the infrastructure, methods, and tools necessary to conduct medical product safety surveillance. Ms Cluchey also supports the Center’s work in comparative effectiveness research policy and projects related to improving regulatory science.
Prior to joining Brookings she was a program officer with the Institute of Medicine (IOM) of the National Academy of Sciences. At IOM, she staffed multiple projects including the Committee on Comparative Effectiveness Research Prioritization, where she helped to write the report Initial Prioritizes for Comparative Effectiveness Research, and served for two years on the Forum on Drug Discovery, Development, and Translation. While working on the Forum, Ms. Cluchey was responsible for several key IOM initiatives involving the science of drug safety, FDA policy, funding models for drug development, and improving the clinical research process.
Prior to joining the IOM in 2006, she worked for the Walter Reed Army Institute of Research’s malaria vaccine development program, where she managed the manufacture, preclinical, and Phase I development of multiple vaccine candidates, and coordinated regulatory submissions. Ms. Cluchey holds a Masters of Science in Biomedical Science and Regulatory Compliance from Hood College and a Bachelor of Arts from Kenyon College.